Lumiliximab (Anti-FceR2 / CD23)

Synonyms: Anti-CD23 Recombinant Antibody

Lumiliximab (Anti-FceR2 / CD23) is a monoclonal antibody targeting CD23, that inhibits allergen-induced responses. MW: 145.5 KD.

Lumiliximab (Anti-FceR2 / CD23)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Lumiliximab (Anti-FceR2 / CD23) is a monoclonal antibody targeting CD23, that inhibits allergen-induced responses. MW: 145.5 KD.

Product Details

CAS No. 357613-86-6
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lumiliximab (Anti-FceR2 / CD23) | Lumiliximab (Anti-FceR2 / CD23) supplier | purchase Lumiliximab (Anti-FceR2 / CD23) | Lumiliximab (Anti-FceR2 / CD23) cost | Lumiliximab (Anti-FceR2 / CD23) manufacturer | order Lumiliximab (Anti-FceR2 / CD23) | Lumiliximab (Anti-FceR2 / CD23) distributor